Can we reliably identify drug targets at the proteome scale using AlphaFold based docking or generative AI?
Artificial Intelligence in the Life Sciences · 2026-06 · 9 · 100167
DOI: 10.1016/j.ailsci.2026.100167 ↗Kurz gefasst
Fachartikel in der Zeitschrift Artificial Intelligence in the Life Sciences, 2026-06. Verfasst von Xiaodong Xing und 3 weiteren Autor:innen. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Tianjin Medical University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Key Research and Development Program of China
- Tianjin Medical University
- National Natural Science Foundation of China
Zitieren
APA
Xing, X., Guo, Y., Wang, T., & Fu, Y. (2026). Can we reliably identify drug targets at the proteome scale using AlphaFold based docking or generative AI?. Artificial Intelligence in the Life Sciences, 9, 100167. https://doi.org/10.1016/j.ailsci.2026.100167
Vancouver
Xing X, Guo Y, Wang T, Fu Y. Can we reliably identify drug targets at the proteome scale using AlphaFold based docking or generative AI?. Artificial Intelligence in the Life Sciences. 2026;9:100167. doi:10.1016/j.ailsci.2026.100167
BibTeX
@article{Xing2026,
author = {Xing, Xiaodong and Guo, Yi and Wang, Ting and Fu, Yuan},
title = {Can we reliably identify drug targets at the proteome scale using AlphaFold based docking or generative AI?},
journal = {Artificial Intelligence in the Life Sciences},
year = {2026},
volume = {9},
pages = {100167},
doi = {10.1016/j.ailsci.2026.100167}
}
EUVIMED